BofA raised the firm’s price target on Welltower to $129 from $96 and keeps a Buy rating on the shares. While investors have “long questioned” Welltower’s premium valuation, the firm argues that the stock is “inexpensive” given the company’s future growth potential. The firm’s analysis shows it could be worth $217 per share in 2028, or greater than double Friday’s closing price, which supports Welltower’s continued inclusion on Spector’s Top Pick List and BofA’s Global Research US1 list, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on WELL:
- Welltower, Inc.’s New Sales & Marketing Risk – A Cause for Worry?
- Welltower Announces $3.5 Billion Common Stock Sales Agreement
- Early notable gainers among liquid option names on February 14th
- Welltower to form long-term strategic partnership with Affinity
- Welltower sees FY24 normalized FFO $3.94-$4.10
